RainMed sincerely invite anyone who may be interested in us to visit our booth and learn more about our CAFFRTM FlashAngioTM System at ACC.19 Exhibition.
RainMed group is devoted to a better cardiovascular solution for years. In order to introduce our technology and products to more cardiologists and technicians around the world, we genuinely welcome your presence at the ACC.19 Exhibition, New Orleans in March this year.
The Exhibition details
Exhibition Center: New Orleans Ernest N. Morial Convention Center.
Booth Number: 2510
Date: March 16th to 18th,2019
It would be a great pleasure to meet you at the exhibition. We would be glad to answer any questions you may have about our products and look forward to further discussions with you. You are welcome to contact us by e-mail in advance with your apporximate time of attendance, so that we can make better arrangement for you according to your schedule.
We would also like to invite you to follow Director Huo Yong's summary article on the clinical trial of our products Accuracy of Angiography-Based Fractional Flow Reserve from A Specially-Designed Computational Fluid Dynamic Method.
About CAFFRTM FlashAngioTM System
The main purpose of our products is to further reduce the occurrence of MACE (Major Adverse Cardiac Events). Compared with conventional FFR assessment methods, CAFFRTM (Coronary Artery Fractional Flow Reserve) FlashAngioTM System has many significant advantages. By using enhanced Computerized Flow Dynamic (CFD) approach, the system provided >96% accuracy, which is the highest among current FFR assessment methods. Our delicately designed CFD algorithm provides resolution to Navier-Stokes formula in 30s. FlashPressureTM provides exceptional correlation and accuracy in critical section. In addition, our real-time biosensor can provide comprehensive Physiological parameters in all stages of cardiac cycle.
About Suzhou RainMed Medical Technology Co. Ltd.
Suzhou RainMed Medical Technology Co., Ltd. is a high-tech enterprise specializing in the development of accurate diagnosis and treatment of cardiovascular diseases. The company has independent development capacity for medical devices with clinically approved quality and has obtained more than 20 patents. The product has been clinically recognized and approved by a number of medical facilities in China and abroad.
For further information, please contact:
RainMed International Department：InternationalBD@rainmed.com